32456274|t|Anti-aggregation Effects of Phenolic Compounds on alpha-synuclein.
32456274|a|The aggregation and deposition of alpha-synuclein (alphaS) are major pathologic features of Parkinson's disease, dementia with Lewy bodies, and other alpha-synucleinopathies. The propagation of alphaS pathology in the brain plays a key role in the onset and progression of clinical phenotypes. Thus, there is increasing interest in developing strategies that attenuate alphaS aggregation and propagation. Based on cumulative evidence that alphaS oligomers are neurotoxic and critical species in the pathogenesis of alpha-synucleinopathies, we and other groups reported that phenolic compounds inhibit alphaS aggregation including oligomerization, thereby ameliorating alphaS oligomer-induced cellular and synaptic toxicities. Heterogeneity in gut microbiota may influence the efficacy of dietary polyphenol metabolism. Our recent studies on the brain-penetrating polyphenolic acids 3-hydroxybenzoic acid (3-HBA), 3,4-dihydroxybenzoic acid (3,4-diHBA), and 3-hydroxyphenylacetic acid (3-HPPA), which are derived from gut microbiota-based metabolism of dietary polyphenols, demonstrated an in vitro ability to inhibit alphaS oligomerization and mediate aggregated alphaS-induced neurotoxicity. Additionally, 3-HPPA, 3,4-diHBA, 3-HBA, and 4-hydroxybenzoic acid significantly attenuated intracellular alphaS seeding aggregation in a cell-based system. This review focuses on recent research developments regarding neuroprotective properties, especially anti-alphaS aggregation effects, of phenolic compounds and their metabolites by the gut microbiome, including our findings in the pathogenesis of alpha-synucleinopathies.
32456274	28	46	Phenolic Compounds	Chemical	-
32456274	50	65	alpha-synuclein	Gene	6622
32456274	101	116	alpha-synuclein	Gene	6622
32456274	118	124	alphaS	Gene	112935892
32456274	159	178	Parkinson's disease	Disease	MESH:D010300
32456274	180	205	dementia with Lewy bodies	Disease	MESH:D020961
32456274	217	240	alpha-synucleinopathies	Disease	MESH:D000080874
32456274	261	267	alphaS	Gene	112935892
32456274	436	442	alphaS	Gene	112935892
32456274	506	512	alphaS	Gene	112935892
32456274	527	537	neurotoxic	Disease	MESH:D020258
32456274	582	605	alpha-synucleinopathies	Disease	MESH:D000080874
32456274	641	659	phenolic compounds	Chemical	-
32456274	668	674	alphaS	Gene	112935892
32456274	735	741	alphaS	Gene	112935892
32456274	781	791	toxicities	Disease	MESH:D064420
32456274	863	873	polyphenol	Chemical	MESH:D059808
32456274	930	948	polyphenolic acids	Chemical	-
32456274	949	970	3-hydroxybenzoic acid	Chemical	MESH:C032948
32456274	972	977	3-HBA	Chemical	MESH:C032948
32456274	980	1005	3,4-dihydroxybenzoic acid	Chemical	MESH:C009091
32456274	1007	1016	3,4-diHBA	Chemical	MESH:C009091
32456274	1023	1049	3-hydroxyphenylacetic acid	Chemical	MESH:C008069
32456274	1051	1057	3-HPPA	Chemical	-
32456274	1126	1137	polyphenols	Chemical	MESH:D059808
32456274	1183	1189	alphaS	Gene	112935892
32456274	1229	1235	alphaS	Gene	112935892
32456274	1244	1257	neurotoxicity	Disease	MESH:D020258
32456274	1273	1279	3-HPPA	Chemical	-
32456274	1281	1290	3,4-diHBA	Chemical	MESH:C009091
32456274	1292	1297	3-HBA	Chemical	MESH:C032948
32456274	1303	1324	4-hydroxybenzoic acid	Chemical	MESH:C038193
32456274	1364	1370	alphaS	Gene	112935892
32456274	1521	1527	alphaS	Gene	112935892
32456274	1552	1570	phenolic compounds	Chemical	-
32456274	1662	1685	alpha-synucleinopathies	Disease	MESH:D000080874
32456274	Negative_Correlation	MESH:C038193	112935892
32456274	Association	MESH:D020961	112935892
32456274	Association	MESH:D010300	6622
32456274	Association	MESH:D010300	112935892
32456274	Negative_Correlation	MESH:C008069	112935892
32456274	Association	MESH:D000080874	112935892
32456274	Negative_Correlation	MESH:C009091	112935892
32456274	Positive_Correlation	MESH:C008069	MESH:D020258
32456274	Negative_Correlation	MESH:C032948	112935892
32456274	Association	MESH:D000080874	6622
32456274	Positive_Correlation	MESH:D020258	112935892
32456274	Association	MESH:D020961	6622

